Marcus Harrison Email & Phone Number

Manchester, England, GB

Advisory and consultancy for innovation and life science organisations. - Novel drug discovery, biomarker and diagnostics platforms- Strategic, business and operational planning for spinouts and start-ups- Organisation and programme governance

Edinburgh, GB

• The Health and Social Care Data-Driven Innovation (HSCDDI) programme seeks to drive advances in health and social care through the application of data science through collaborations between academics, service providers.
• Provide senior strategic and operational leadership for the delivery of the Data-Driven Innovation initiative
• Ownership, implementation and delivery of the objectives and key deliverables for the Talent; Research; Adoption; Data and Entrepreneurship (TRADE) business plans
• Lead and coordinate the central delivery team
• Oversee the fit-out, occupation and transition to the new Usher building
• Develop strategic partnerships across a wide network of clinical, social care and commercial partners

Alderley, Cheshire, GB

• MDC is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Strategic initiatives link the industry with.
• Responsibilities have included for Programme Management, Finance, Risk, Governance, Legal/IP, IT, HR, Procurement & Facilities
• Strategic and operational planning
• Building the operations team from the ground up
• Established operations of the Lighthouse Laboratory that quickly went on to process 80,000 COVID-19 samples per day
• Working with key stakeholders, funders and board members

Grenville Place Mill Hill, London, GB

• NALIA systems developed a multiplex point of care (POC) platform for the diagnosis of autoimmune and infectious diseases.
• Coordinating technology platform developments
• Supporting fund raising activities.

Cardiff, Wales, GB

• Ceryx Medical is a bioelectronics spinout from the Universities of Bath and Bristol developing unique technologies for reinstating physiologically dynamic feedback controls to the heart.
• Working with founding academics to define the commercial opportunities, clinical route to market and fund raising.

Abingdon, Oxfordshire, GB

• GeneFirst is a molecular diagnostics company working predominantly in the fields of infectious disease, cancer diagnostics and personalised medicine. The technology portfolio includes, highly multiplexed quantitative.
• Obtained regulatory approval (CE Marking) and transfer to manufacturing (ISO 13485) of the company's first product, Papilloplex, which enables the simultaneous detection and genotyping of 14 different high-risk Human.

• A Cardiff University spinout company developing a novel assay technology platform and applications for pre-clinical drug discovery research.
• Responsible for the strategic and commercial direction, and technical delivery of the core technology platform.
• Industrialised an academic biological assay platform and led business development activities to establish a network of key opinion leaders leading to initial national and international collaboration projects.
• Led business development activities for the company’s first collaborations.
• Undertaking fund raising activities and securing grant funding

GB

• Mediwatch Plc (acquired by Laborie in 2014) were designers, manufacturers and suppliers of high-technology urology products for the screening, diagnosis and assessment of a variety of clinical disorders. Mediwatch were.
• Coordinated programmes across the full product lifecycle, including feasibility testing, full development, performance enhancements, coordinating clinical trials (FDA 510k), obtaining regulatory approval (CE marking).
• Undertook business development activities to build a pipeline of new products.
• Oversaw commercialisation of flagship product, including working with key opinion leaders, presenting at conferences, coordinating training programs and meeting with distributors.
• Developed a five year strategic plan for the Biomedical Division, including extension of current product range and route to identifying/in-licensing next generation platform and applications.

Kidlington, Oxfordshire, GB

OGT focus on developing services and innovative products for the academic research and clinical diagnostics markets.Coordinated sales/marketing activities and project management delivering up to 30 projects simultaneously across molecular diagnostics, functional genomics, oncology and microbiology.

Kidlington, Oxfordshire, GB

Established the computational biology group developing core infrastructure, capabilities, informatics systems and software products.

Kidlington, Oxfordshire, GB

GB

Senior scientist within an inter-disciplinary discovery team identifying novel therapeutic and vaccine targets.

Kidlington, Oxfordshire, GB

Developed analytical software and systems for designing DNA microarray probes, analysing large quantities of biological data and data workflows.

Norwich, Norfolk, GB

Post-doctoral research which investigated the effect of the food matrix on flavour release and perception, leading to 20 peer reviewed publications and collaborations in Europe.

Bsc, Physics

Doctor Of Philosophy - Phd, Theoretical Physics